Venetoclax as a cytoreduction therapy for acute promyelocytic leukaemia: A single-centre experience. Qi P, Wang L, Li H, Wu Y, et al. Br J Haematol 2023;203:892-895.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qi P, Wang L, Li H, Wu Y, et al. Venetoclax as a cytoreduction therapy for acute promyelocytic leukaemia: A single-centre experience. Br J Haematol 2023;203:892-895.
PMID: 37731163